Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
-
801
-
802
-
803
-
804
-
805
-
806
-
807
-
808
-
809
Structural Studies of the <i>Methylosinus trichosporium</i> OB3b Soluble Methane Monooxygenase Hydroxylase and Regulatory Component Complex Reveal a Transient Substrate Tunnel
Published 2020“…The kinetics of reaction of O<sub>2</sub> with the diferrous sMMOH:MMOB complex in solution show that use of the MMOB V41R variant decreases the rate constant for O<sub>2</sub> binding >25000-fold without altering the component affinity. …”
-
810
Structural Studies of the <i>Methylosinus trichosporium</i> OB3b Soluble Methane Monooxygenase Hydroxylase and Regulatory Component Complex Reveal a Transient Substrate Tunnel
Published 2020“…The kinetics of reaction of O<sub>2</sub> with the diferrous sMMOH:MMOB complex in solution show that use of the MMOB V41R variant decreases the rate constant for O<sub>2</sub> binding >25000-fold without altering the component affinity. …”
-
811
-
812
-
813
-
814
Kinetic Study of the Effects of Inhibitors on the Catalyzed Dehydration of HCO<sub>3</sub><sup>-</sup> by Copper(II) Complexes [Tp<sup>Ph</sup>]CuX (X<sup>-</sup> = OH<sup>-</sup>,...
Published 2002“…The structure of <b>3</b> was determined by X-ray diffraction analysis. Crystals of <b>3</b> (C<sub>37</sub>H<sub>30</sub>BCuN<sub>9</sub>S) are triclinic, space group <i>P</i>1̄ with <i>a</i> = 11.997(3) Å, <i>b</i> = 12.116(3) Å, <i>c</i> = 13.384(4) Å, <i>α</i> = 81.088(5)°, <i>β</i> = 79.289(6)°, <i>γ</i> = 68.668(5)°, <i>V</i> = 1772.4(8) Å<sup>3</sup>, and<i> Z</i> = 2. …”
-
815
Liquid–Liquid Phase Separation of Peptide/Oligonucleotide Complexes in Crowded Macromolecular Media
Published 2020“…To reveal how the crowded cell interior regulates the MLOs, we chose the coacervates formed by peptide S5 and single-stranded oligonucleotide (ss-oligo) at 1:1 charge ratio and investigated the phase separation processes in polyacrylamide (PAM) and poly(ethylene oxide) (PEO) media at varying concentrations. …”
-
816
Liquid–Liquid Phase Separation of Peptide/Oligonucleotide Complexes in Crowded Macromolecular Media
Published 2020“…To reveal how the crowded cell interior regulates the MLOs, we chose the coacervates formed by peptide S5 and single-stranded oligonucleotide (ss-oligo) at 1:1 charge ratio and investigated the phase separation processes in polyacrylamide (PAM) and poly(ethylene oxide) (PEO) media at varying concentrations. …”
-
817
Liquid–Liquid Phase Separation of Peptide/Oligonucleotide Complexes in Crowded Macromolecular Media
Published 2020“…To reveal how the crowded cell interior regulates the MLOs, we chose the coacervates formed by peptide S5 and single-stranded oligonucleotide (ss-oligo) at 1:1 charge ratio and investigated the phase separation processes in polyacrylamide (PAM) and poly(ethylene oxide) (PEO) media at varying concentrations. …”
-
818
-
819
GSK343 decreased tumor stemness.
Published 2021“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”
-
820
Receiver operating characteristic curves for mucosal healing versus (A) two-item patient-reported outcome (PRO2), (B) decrease in PRO2 below baseline, (C) Lichtiger clinical activity index (CAI), and (D) decrease in CAI below baseline.
Published 2017“…<p>Receiver operating characteristic curves for mucosal healing versus (A) two-item patient-reported outcome (PRO2), (B) decrease in PRO2 below baseline, (C) Lichtiger clinical activity index (CAI), and (D) decrease in CAI below baseline.…”